In breast cancer, IL-1β has also been shown to up-regulate matrix metalloproteinase (MMP) 2, and MMP9, thereby promoting invasiveness and vasculogenic mimicry of tumour cells (Nisar et al., 2021). This evidence concerns the gene IL1B and neoplasm.